Evidence map›Paper›PMID 29694440›Full record

ArticlePloS one2018

Characterization of recent and minimally passaged Brazilian dengue viruses inducing robust infection in rhesus macaques.

Maria Beatriz Borges, Renato Sergio Marchevsky, Ygara S Mendes, Luiz Gustavo Mendes, Ana Claudia Duarte, Michael Cruz, Ana Maria Bispo de Filippis, Pedro Fernando C Vasconcelos, Marcos Freire, Akira Homma and 7 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Isolation and molecular characterization of dengue virus clinical isolates from pediatric patients in New Delhi.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2019
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 3 countries.

Maria Beatriz BorgesFiocruz, Rio de Janeiro, Brazil.
Renato Sergio MarchevskyFiocruz, Rio de Janeiro, Brazil.
Ygara S MendesFiocruz, Rio de Janeiro, Brazil.
Luiz Gustavo MendesFiocruz, Rio de Janeiro, Brazil.
Ana Claudia DuarteFiocruz, Rio de Janeiro, Brazil.
Michael CruzGSK, Rockville, Maryland, United States of America.
Ana Maria Bispo de FilippisFiocruz, Rio de Janeiro, Brazil.
Pedro Fernando C VasconcelosInstituto Evandro Chagas, MoH, Ananindeua, Brazil.
Marcos FreireFiocruz, Rio de Janeiro, Brazil.
Akira HommaFiocruz, Rio de Janeiro, Brazil.
Sally MossmanGSK, Rockville, Maryland, United States of America.
Edith LepineGSK, Rockville, Maryland, United States of America.
Yannick VanloubbeeckGSK, Rixensart, Belgium.
Clarisse LorinGSK, Rixensart, Belgium.
Marie-Pierre MaliceGSK, Rixensart, Belgium.
Elena CarideFiocruz, Rio de Janeiro, Brazil.
Lucile WarterGSK, Rixensart, Belgium.ORCID 0000-0001-7419-9284
Fundação Oswaldo Cruz · BRGlaxoSmithKline (Belgium) · BEGlaxoSmithKline (United States) · USInstituto Evandro Chagas · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The macaque is widely accepted as a suitable model for preclinical characterization of dengue vaccine candidates. However, the only vaccine for which both preclinical and clinical efficacy results were reported so far showed efficacy levels that were substantially different between macaques and humans. We hypothesized that this model's predictive capacity may be improved using recent and minimally passaged dengue virus isolates, and by assessing vaccine efficacy by characterizing not only the post-dengue virus challenge viremia/RNAemia but also the associated-cytokine profile. Ten recent and minimally passaged Brazilian clinical isolates from the four dengue virus serotypes were tested for their infectivity in rhesus macaques. For the strains showing robust replication capacity, the associated-changes in soluble mediator levels, and the elicited dengue virus-neutralizing antibody responses, were also characterized. Three isolates from dengue virus serotypes 1, 2 and 4 induced viremia of high magnitude and longer duration relative to previously reported viremia kinetics in this model, and robust dengue virus-neutralizing antibody responses. Consistent with observations in humans, increased MCP-1, IFN-γ and VEGF-A levels, and transiently decreased IL-8 levels were detected after infection with the selected isolates. These results may contribute to establishing a dengue macaque model showing a higher predictability for vaccine efficacy in humans.

Indexed as

AnimalsAntibodies, NeutralizingAntibodies, ViralBrazilChemokine CCL2Chlorocebus aethiopsDengueDengue VirusDown-RegulationInterferon-gammaInterleukin-8Macaca mulattaSerogroupUp-RegulationVascular Endothelial Growth Factor AVero CellsAntibodies, NeutralizingAntibodies, ViralChemokine CCL2Interferon-gammaInterleukin-8Vascular Endothelial Growth Factor A

Identifiers

PMID29694440
PMCPMC5919018
OpenAlexW2803064139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.